JPWO2020231977A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020231977A5 JPWO2020231977A5 JP2021568200A JP2021568200A JPWO2020231977A5 JP WO2020231977 A5 JPWO2020231977 A5 JP WO2020231977A5 JP 2021568200 A JP2021568200 A JP 2021568200A JP 2021568200 A JP2021568200 A JP 2021568200A JP WO2020231977 A5 JPWO2020231977 A5 JP WO2020231977A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridazin
- pyridin
- fluoro
- oxy
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962846896P | 2019-05-13 | 2019-05-13 | |
US62/846,896 | 2019-05-13 | ||
PCT/US2020/032446 WO2020231977A1 (en) | 2019-05-13 | 2020-05-12 | Compounds for treating huntington's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022533120A JP2022533120A (ja) | 2022-07-21 |
JPWO2020231977A5 true JPWO2020231977A5 (lt) | 2023-05-16 |
Family
ID=70919171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021568200A Pending JP2022533120A (ja) | 2019-05-13 | 2020-05-12 | ハンチントン病を処置するための化合物 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220204478A1 (lt) |
EP (2) | EP4219466A1 (lt) |
JP (1) | JP2022533120A (lt) |
KR (1) | KR20220022114A (lt) |
CN (1) | CN114245794A (lt) |
AU (1) | AU2020277027A1 (lt) |
BR (1) | BR112021022624A2 (lt) |
CA (1) | CA3139821A1 (lt) |
IL (1) | IL287945A (lt) |
MX (1) | MX2021013854A (lt) |
SG (1) | SG11202112504YA (lt) |
WO (1) | WO2020231977A1 (lt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110946865B (zh) | 2015-12-10 | 2024-01-26 | Ptc医疗公司 | 用于治疗亨廷顿病的方法 |
BR112019025740A2 (pt) | 2017-06-05 | 2020-06-23 | Ptc Therapeutics, Inc. | Compostos para tratar a doença de huntington |
BR112019027719A2 (pt) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics, Inc. | métodos para tratar a doença de huntington |
US11382918B2 (en) | 2017-06-28 | 2022-07-12 | Ptc Therapeutics, Inc. | Methods for treating Huntington's Disease |
JP2021506978A (ja) | 2017-12-22 | 2021-02-22 | ラヴェンナ ファーマシューティカルズ,インコーポレイテッド | ホスファチジルイノシトールリン酸キナーゼ阻害剤としてのアミノピリジン誘導体 |
SG11202009212WA (en) | 2018-03-27 | 2020-10-29 | Ptc Therapeutics Inc | Compounds for treating huntington's disease |
EA202092896A1 (ru) | 2018-06-27 | 2021-04-13 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона |
TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
WO2021207453A1 (en) * | 2020-04-09 | 2021-10-14 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
EP4149937A1 (en) | 2020-05-13 | 2023-03-22 | CHDI Foundation, Inc. | Htt modulators for treating huntington's disease |
KR20240069714A (ko) | 2021-08-25 | 2024-05-20 | 피티씨 테라퓨틱스, 인크. | Nlrp3 억제제 |
WO2023034836A1 (en) * | 2021-08-30 | 2023-03-09 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
WO2023034827A1 (en) * | 2021-08-30 | 2023-03-09 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
WO2023131277A1 (zh) * | 2022-01-07 | 2023-07-13 | 药捷安康(南京)科技股份有限公司 | Nlrp3炎症小体抑制剂及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9447075B2 (en) * | 2011-08-02 | 2016-09-20 | The Brigham And Women's Hospital, Inc. | Pyridazine derivatives as EAAT2 activators |
MY174339A (en) * | 2012-08-13 | 2020-04-09 | Novartis Ag | 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions |
CN110946865B (zh) * | 2015-12-10 | 2024-01-26 | Ptc医疗公司 | 用于治疗亨廷顿病的方法 |
EA202092896A1 (ru) * | 2018-06-27 | 2021-04-13 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона |
-
2020
- 2020-05-12 SG SG11202112504YA patent/SG11202112504YA/en unknown
- 2020-05-12 MX MX2021013854A patent/MX2021013854A/es unknown
- 2020-05-12 KR KR1020217036718A patent/KR20220022114A/ko unknown
- 2020-05-12 WO PCT/US2020/032446 patent/WO2020231977A1/en unknown
- 2020-05-12 JP JP2021568200A patent/JP2022533120A/ja active Pending
- 2020-05-12 EP EP23162466.9A patent/EP4219466A1/en active Pending
- 2020-05-12 CA CA3139821A patent/CA3139821A1/en active Pending
- 2020-05-12 US US17/610,617 patent/US20220204478A1/en active Pending
- 2020-05-12 CN CN202080050837.0A patent/CN114245794A/zh active Pending
- 2020-05-12 EP EP20729481.0A patent/EP3969446B1/en active Active
- 2020-05-12 AU AU2020277027A patent/AU2020277027A1/en not_active Abandoned
- 2020-05-12 BR BR112021022624A patent/BR112021022624A2/pt unknown
-
2021
- 2021-11-09 IL IL287945A patent/IL287945A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230234958A1 (en) | Shp2 phosphatase inhibitors and methods of use thereof | |
US11591336B2 (en) | Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors | |
US11420958B2 (en) | Aryl and heteroaryl substituted indole compounds | |
JPWO2020005873A5 (lt) | ||
US10988459B2 (en) | Bicyclic lactams and methods of use thereof | |
JP6435323B2 (ja) | 炎症性障害の治療のための新規化合物及びその医薬組成物 | |
JPWO2019191092A5 (lt) | ||
JPWO2020231977A5 (lt) | ||
US11299501B2 (en) | Diazaindole compounds | |
JPWO2019191229A5 (lt) | ||
JPWO2020005877A5 (lt) | ||
JP2014521711A5 (lt) | ||
JP2016525092A5 (lt) | ||
US20220204478A1 (en) | Compounds for treating huntington's disease | |
US10214537B2 (en) | Bicyclic heteroaryl amine compounds | |
HUE032770T2 (en) | New NK-3 receptor selective antagonist compounds, pharmaceutical compositions and methods for use in NK-3 receptor mediated disorders | |
JP2013523884A5 (lt) | ||
JP2011511034A5 (lt) | ||
JP2017518326A5 (lt) | ||
RU2013136778A (ru) | Ингибиторы гистондезацетилазы, композиции и способы их применения | |
JP2014511355A5 (lt) | ||
RU2008145504A (ru) | Новое соединение пиперазина и его применение в качестве ингибитора hcv полимеразы | |
JP2020526549A5 (lt) | ||
JPWO2022173033A5 (lt) | ||
US20230085472A1 (en) | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH cGAS |